Consistently, NFIL3 expression was correlated with a poor prognosis in brain cancer (MGH-glioma) (OS: total number = 50, HR = 1.93, Cox P = 0.011640) (Figure 3F), bladder cancer (DSS: total number = 165, HR = 1.47, Cox P = 0.029915) (Figure 3G), blood cancer (OS: total number = 79, HR = 1.58, Cox P = 0.036644) (Figure 3H) and OS in lung cancer (OS: total number = 79, HR = 1.95, Cox P = 0.044052) (Figure 3I). The gene discussed is NFIL3; the disease is urinary bladder cancer.